SKX vs. EDIT

Last updated Jun 13, 2026

SKX (Skechers U.S.A., Inc.) and EDIT (Editas Medicine, Inc.) are both stocks. SKX operates in Footwear & Accessories (Consumer Cyclical), while EDIT operates in Biotechnology (Healthcare). At a 0.25 correlation, their price movements are largely independent.

Performance

SKX vs. EDIT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Skechers U.S.A., Inc. (SKX) and Editas Medicine, Inc. (EDIT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

SKX

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

EDIT

• 1D: 2.46%
• 1M: -4.58%
• YTD: 21.95%
• 6M: -1.19%
• 1Y: 26.90%
• 3Y*: -39.82%
• 5Y*: -41.79%
• 10Y*: -22.22%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SKX vs. EDIT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SKX Skechers U.S.A., Inc.	0.00%	-6.11%	7.86%	48.61%	-3.34%	20.76%	-16.79%	88.69%	-39.51%	53.95%
EDIT Editas Medicine, Inc.	21.95%	61.42%	-87.46%	14.21%	-66.59%	-62.13%	136.78%	30.15%	-25.97%	89.34%

Correlation

The correlation between SKX and EDIT is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.02
Correlation (3Y) Calculated over the trailing 3-year period	0.22
Correlation (5Y) Calculated over the trailing 5-year period	0.30
Correlation (10Y) Calculated over the trailing 10-year period	0.26
Correlation (All Time) Calculated using the full available price history since Feb 3, 2016	0.25

Over the past year, the correlation between SKX and EDIT has dropped to 0.02 - well below their long-term average of 0.25, suggesting their price drivers have been diverging.

Fundamentals

Market Cap SKX : $9.55B EDIT : $244.70M
EPS SKX : $4.40 EDIT : -$1.21
PS Ratio SKX : 1.01 EDIT : 6.29
PB Ratio SKX : 2.00 EDIT : 55.51
Total Revenue (TTM) SKX : $9.41B EDIT : $35.86M
Gross Profit (TTM) SKX : $4.96B EDIT : $35.86M
EBITDA (TTM) SKX : $1.07B EDIT : -$76.66M

Return for Risk

SKX vs. EDIT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SKX

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

EDIT

EDIT Risk / Return Rank: 51
EDIT Sharpe Ratio Rank: 48
EDIT Sortino Ratio Rank: 56
EDIT Omega Ratio Rank: 53
EDIT Calmar Ratio Rank: 49
EDIT Martin Ratio Rank: 48

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SKX vs. EDIT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Skechers U.S.A., Inc. (SKX) and Editas Medicine, Inc. (EDIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	SKX	EDIT	Difference
Sharpe ratio: Return per unit of total volatility	—	0.16	—
Sortino ratio: Return per unit of downside risk	—	0.98	—
Omega ratio: Gain probability vs. loss probability	—	1.11	—
Calmar ratio: Return relative to maximum drawdown	—	0.25	—
Martin ratio: Return relative to average drawdown	—	0.43	—

Drawdowns

Drawdown Indicators

	SKX	EDIT	Difference
Max Drawdown Largest peak-to-trough decline	—	-98.92%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-59.88%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-91.18%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-98.66%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-98.92%	—
Current Drawdown Current decline from peak	—	-97.24%	—
Average Drawdown Average peak-to-trough decline	—	-62.63%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	34.03%	—

Volatility

Volatility by Period

	SKX	EDIT	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	32.34%	—
Volatility (6M) Calculated over the trailing 6-month period	—	61.63%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	94.75%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	94.12%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	83.80%	—

Dividends

SKX vs. EDIT - Dividend Comparison

Neither SKX nor EDIT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both SKX and EDIT in my portfolio?

SKX and EDIT have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.